Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (91-100 of 416) with videos related to

Pageof 42
Sort By:
European Radiology|March 29, 2003
Contrast-enhanced computed tomographic colonography in the follow-up of colorectal cancer patients: a feasibility studyAndrea Laghi, Riccardo Iannaccone, Emilio Bria, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 31, 2011
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical researchMaria Bonomi, Sara Pilotto, Michele Milella, et al.
Translational Lung Cancer Research|January 23, 2016
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancerSara Pilotto, Luisa Carbognin, Niki Karachaliou, et al.
The Oncologist|February 12, 2016
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant SettingLuisa Carbognin, Sara Pilotto, Rolando Nortilli, et al.
Current Problems in Cancer|September 7, 2021
Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLCSabrina Rossi, Paola Damiano, Luca Toschi, et al.
Eclinicalmedicine|January 30, 2023
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysisLuca Mastrantoni, Armando Orlandi, Antonella Palazzo, et al.
Cancer|January 8, 2005
Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinomaEmilio Bria, Diana Giannarelli, Alessandra Felici, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2020
The Anticancer Efficacy of Immune Checkpoint Inhibitors According to Patients' Age: A Systematic Review and Meta-AnalysisChiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
Translational Cancer Research|February 4, 2022
Long-term survivors with immunotherapy in advanced NSCLC: is 'cure' within reach?Sara Monteverdi, Emanuele Vita, Giulia Sartori, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2025
Immunotherapy in advanced non-small cell lung cancer: What to do for the 'Invisible' patients after IPSOS trial results?Cesare Gridelli, Ilaria Attili, Chiara Bennati, et al.
Pageof 42

Showing results (91-100 of 416) with videos related to

Sort By:
Pageof 42
European Radiology|March 29, 2003
Contrast-enhanced computed tomographic colonography in the follow-up of colorectal cancer patients: a feasibility studyAndrea Laghi, Riccardo Iannaccone, Emilio Bria, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 31, 2011
Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical researchMaria Bonomi, Sara Pilotto, Michele Milella, et al.
Translational Lung Cancer Research|January 23, 2016
Moving towards a customized approach for drug development: lessons from clinical trials with immune checkpoint inhibitors in lung cancerSara Pilotto, Luisa Carbognin, Niki Karachaliou, et al.
The Oncologist|February 12, 2016
Predictive and Prognostic Role of Tumor-Infiltrating Lymphocytes for Early Breast Cancer According to Disease Subtypes: Sensitivity Analysis of Randomized Trials in Adjuvant and Neoadjuvant SettingLuisa Carbognin, Sara Pilotto, Rolando Nortilli, et al.
Current Problems in Cancer|September 7, 2021
Uncommon single and compound EGFR mutations: clinical outcomes of a heterogeneous subgroup of NSCLCSabrina Rossi, Paola Damiano, Luca Toschi, et al.
Eclinicalmedicine|January 30, 2023
The likelihood of being helped or harmed as a patient-centred tool to assess cyclin dependent kinase 4/6 inhibitors clinical impact and safety in metastatic breast cancer: a systematic review and sensitivity-analysisLuca Mastrantoni, Armando Orlandi, Antonella Palazzo, et al.
Cancer|January 8, 2005
Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinomaEmilio Bria, Diana Giannarelli, Alessandra Felici, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 22, 2020
The Anticancer Efficacy of Immune Checkpoint Inhibitors According to Patients' Age: A Systematic Review and Meta-AnalysisChiara Ciccarese, Roberto Iacovelli, Emilio Bria, et al.
Translational Cancer Research|February 4, 2022
Long-term survivors with immunotherapy in advanced NSCLC: is 'cure' within reach?Sara Monteverdi, Emanuele Vita, Giulia Sartori, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2025
Immunotherapy in advanced non-small cell lung cancer: What to do for the 'Invisible' patients after IPSOS trial results?Cesare Gridelli, Ilaria Attili, Chiara Bennati, et al.
Pageof 42